WO2002031130A1 - Manipulation of soluble carbohydrates - Google Patents
Manipulation of soluble carbohydrates Download PDFInfo
- Publication number
- WO2002031130A1 WO2002031130A1 PCT/AU2001/001275 AU0101275W WO0231130A1 WO 2002031130 A1 WO2002031130 A1 WO 2002031130A1 AU 0101275 W AU0101275 W AU 0101275W WO 0231130 A1 WO0231130 A1 WO 0231130A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- sequence
- sequences
- variants
- functionally active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
- C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1062—Sucrose synthase (2.4.1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1066—Sucrose phosphate synthase (2.4.1.14)
Definitions
- the present invention relates to nucleic acid fragments encoding amino acid sequences for enzymes and transporter proteins involved in the metabolism and/or transport of soluble carbohydrates, such as sucrose and fructan, and the use thereof for the modification of soluble carbohydrate metabolism and/or transport in plants.
- sucrose phosphate synthase The pathway of sucrose synthesis involves three key enzymes: fructose- 1 ,6-biphosphatase, sucrose phosphate synthase (SPS) and phosphatase.
- Fructose-1 ,6-biphosphatase catalyses the synthesis of fructose-6-phosphate from fructose-1 ,6-biphosphate.
- Sucrose phosphate synthase (SPS) activity will produce sucrose phosphate from fructose-6-phosphate and UDP-glucose. The sucrose phosphate is then coverted to sucrose by phosphatase action.
- Sucrose phosphate synthase plays a very important role as the limiting factor in partitioning of carbon sources.
- the enhancement of SPS activity in plants thus may increase the ability of the source function.
- sucrose synthase In plants the breakdown of sucrose to fructose and glucose can be catalysed by invertase (INV) or sucrose synthase (SS). These enzymes are central to sucrose metabolism and they are involved in key physiological processes, such as source-sink interactions and carbohydrate partitioning. Invertases can be divided into neutral (cytosolic) and acid (vacuolar and apoplastic) classes. Sucrose synthase (SS) plays various roles in the synthesis and degradation of sucrose as well as in the flow of carbon from one plant organ to another.
- Sucrose transport is a fundamental process for the allocation of assimilates in plants.
- Sucrose is the primary carbohydrate for long-distance transport of carbon assimilates through the vascular system in many plant species.
- Sucrose transporters ST are involved in sucrose phloem loading and transport in plants.
- SST sucrose:sucrose 1 -fructosyltransferase
- FFT fructan-fructan 1- fructosyltransferase
- SFT sucrose-fructan 6-fructosyltransferase
- Fructans are associated with various advantageous characters in forage grasses, such as cold and drought tolerance, increased tiller survival, enhanced persistence, good regrowth after cutting or grazing, improved recovery from stress and early spring growth. High amounts of fructans have been found to accumulate in ryegrasses (Lolium species) and fescues (Festuca species) in response to environmental stresses such as drought and cold.
- Sugars affect growth and development throughout the plant life cycle, from germination to flowering to senescence.
- Sugars are not only important energy sources in plants; they are also central regulatory molecules controlling physiology, metabolism and gene expression.
- Sugars are physiological signals repressing or activating plant genes involved in many essential processes, including photosynthesis, glyoxylate metabolism, respiration, starch and sucrose synthesis and breakdown, nitrogen metabolism, pathogen defense, wounding response, senescence, pigmentation and cell cycle regulation.
- Partitioning of assimilate between individual tissues and organs is essential for growth and development in higher plants. Sink-source interactions are closely associated to crop yields.
- soluble carbohydrates such as fructans and sucrose in forage grasses contribute significantly to the readily available energy in the feed for grazing ruminant animals.
- the fermentation processes in the rumen require considerable readily available energy.
- the improvement of the readily available energy in the rumen can increase the efficiency of rumen digestion.
- An increased efficiency in rumen digestion leads to an improved conversion of the forage protein fed to the ruminant animal into milk or meat, and to a reduction in nitrogenous waste as environmental pollutant.
- soluble carbohydrate metabolism synthesis and degradation
- methods of manipulating soluble carbohydrate metabolism (synthesis and degradation) and/or transport in plants including grass species such as ryegrasses (Lolium species) and fescues (Festuca species), and legumes such as clovers (Trifolium species), lucerne and medics (Medicago species).
- grass species such as ryegrasses (Lolium species) and fescues (Festuca species)
- legumes such as clovers (Trifolium species), lucerne and medics (Medicago species).
- Perennial ryegrass (Lolium perenne L.) is a key pasture grass in temperate climates throughout the world. Perennial ryegrass is also an important turf grass.
- Clovers Trifolium species
- white clover T. repens
- red clover T. pratense
- subterranean clover T. subterraneum
- lucerne M. sativa
- medics Medicago species
- nucleic acid sequences encoding some of the enzymes involved in soluble carbohydrate metabolism and transport have been isolated for certain species of plants, there remains a need for materials useful in the modification of soluble carbohydrate metabolism and transport, for example sucrose metabolism, sucrose transport and fructan metabolism, in a wide range of plants, particularly in forage grasses and legumes including ryegrasses and fescues, and for methods for their use. There remains further a need for materials useful in engineering fructan accumulation in plant species which are naturally fructan-devoid.
- the present invention provides substantially purified or isolated nucleic acids or nucleic acid fragments encoding amino acid sequences for the following enzymes or transporter proteins from a ryegrass (Lolium) or fescue (Festuca) species, or functionally active fragments or variants thereof: sucrose phosphate synthase (SPS), invertase (INV), sucrose synthase (SS), sucrose transporter (ST), sucrose:sucrose 1 -fructosyltransferase (SST), fructa fructan 1 -fructosyltransferase (FFT), and sucrose:fructan 6- fructosyltransferase (SFT)
- the present invention also provides substantially purified or isolated nucleic acids or nucleic acid fragments encoding amino acid sequences for a class of proteins which are related to SPS, INV, SS, ST, SST, FFT and SFT, or functionally active fragments or variants thereof.
- proteins are referred to herein as SPS- like, INV-like, SS-like, ST-like, SST-like, FFT-like and SFT-like, respectively.
- the ryegrass (Lolium) or fescue (Festuca) species may be of any suitable type, including Italian or annual ryegrass, perennial ryegrass, tall fescue, meadow fescue and red fescue.
- the species is a ryegrass, more preferably perennial ryegrass (L perenne).
- the nucleic acid or nucleic acid fragment may be of any suitable type and includes DNA (such as cDNA or genomic DNA) and RNA (such as mRNA) that is single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases, and combinations thereof.
- isolated means that the material is removed from its original environment (eg. the natural environment if it is naturally occurring). For example, a naturally occurring nucleic acid present in a living plant is not isolated, but the same nucleic acid separated from some or all of the coexisting materials in the natural system, is isolated.
- Such nucleic acids could be part of a vector and/or such nucleic acids could be part of a composition, and still be isolated in that such a vector or composition is not part of its natural environment.
- nucleic acids or nucleic acid fragments could be assembled to form a consensus contig.
- the term "consensus contig” refers to a nucleotide sequence that is assembled from two or more constituent nucleotide sequences that share common or overlapping regions of sequence homology.
- the nucleotide sequence of two or more nucleic acids or nucleic acid fragments can be compared and aligned in order to identify common or overlapping sequences.
- sequences and thus their corresponding nucleic acids or nucleic acid fragments
- the substantially purified or isolated nucleic acid or nucleic acid fragment encoding a SPS or SPS- like protein includes a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 1 , 3, 5, 6, 8, 9, 11 , 12, 14, 15 and 17 hereto; (Sequence ID Nos: 1 , 3, 5 and 6, 7, 9 and 10, 11, 13 and 14, 15, 17 and 18, 19 and 21 to 23, respectively) (b) complements of the sequences recited in (a) ; (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- INV or INV-like protein includes a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 18, 20, 21 , 23, 24, 26, 27, 29, 30, 32, 33, 35, 36, 38, 64 and 69 hereto (Sequence ID Nos: 24, 26 to 30, 31 , 33 to 36, 37, 39 and 40, 41 , 43 to 58, 59, 61 and 62, 63, 65 to 70, 71 , 73 to 75, 112 and 114, respectively); (b) complements of the sequences recited in (a) ; (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- the substantially purified or isolated nucleic acid or nucleic acid fragment encoding an SS or SS-like protein includes a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 39, 41 , 43, 44, 46 and 74 hereto (Sequence ID Nos: 76, 78, 80 to 82, 83, 85 and 86, and 116, respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- the substantially purified or isolated nucleic acid or nucleic acid fragment encoding a ST or ST-like protein includes a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 47, 49, 50, 52, 53, and 55 hereto (Sequence ID Nos: 87, 89 and 90, 91 , 93 to 96, 97, and 99 and 100, respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- the substantially purified or isolated nucleic acid or nucleic acid fragment encoding a SST or SST-like protein includes a nucleotide sequence selected from the group consisting of (a) sequence shown in Figure 56 hereto (Sequence ID No: 101); (b) a complement of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- the substantially purified or isolated nucleic acid or nucleic acid fragment encoding a FFT or FFT-like protein includes a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 58 and 60 hereto (Sequence ID Nos: 103 and 105 to 109, respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- the substantially purified or isolated nucleic acid fragment encoding a SFT or SFT-like protein includes a nucleotide sequence selected from the group consisting of (a) sequence shown in Figure 61 hereto (Sequence ID No: 110); (b) complement of the sequence recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); and (d) functionally active fragments and variants of the sequences recited in (a), (b) and (c).
- the fragment or variant encodes a polypeptide capable of modifying soluble carbohydrate metabolism and/or transport, for example sucrose biosynthesis, sucrose degradation, sucrose transport, fructan biosynthesis and/or fructan degradation, in a plant.
- Such variants include naturally occurring allelic variants and non-naturally occurring variants. Additions, deletions, substitutions and derivatizations of one or more of the nucleotides are contemplated so long as the modifications do not result in loss of functional activity of the fragment or variant.
- the functionally active fragment or variant has at least approximately 80% identity to the relevant part of the above mentioned sequence, more preferably at least approximately 90% identity, most preferably at least approximately 95% identity.
- Such functionally active variants and fragments include, for example, those having nucleic acid changes which result in conservative amino acid substitutions of one or more residues in the corresponding amino acid sequence.
- the fragment has a size of at least 10 nucleotides, more preferably at least 15 nucleotides, most preferably at least 20 nucleotides.
- sucrose metabolism-like enzymes, sucrose transporter or sucrose transporter-like proteins, and fructan metabolism or fructan metabolism-like enzymes have been isolated and identified.
- the nucleic acids and nucleic acid fragments of the present invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridisation, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g. polymerase chain reaction, ligase chain reaction).
- genes encoding other sucrose metabolism or sucrose metabolism-like enzymes, sucrose transporter or sucrose transporter-like proteins, and fructan metabolism or fructan metabolism-like enzymes, either as cDNAs or genomic DNAs may be isolated directly by using all or a portion of the nucleic acids or nucleic acid fragments of the present invention as hybridisation probes to screen libraries from the desired plant employing the methodology well known to those skilled in the art.
- Specific oligonucleotide probes based upon the nucleic acid sequences of the present invention may be designed and synthesized by methods known in the art.
- sequences may be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labelling, nick translation, or end-labelling techniques, or RNA probes using available in vitro transcription systems.
- specific primers may be designed and used to amplify a part or all of the sequences of the present invention.
- the resulting amplification products may be labelled directly during amplification reactions or labelled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency.
- short segments of the nucleic acids or nucleic acid fragments of the present invention may be used in amplification protocols to amplify longer nucleic acids or nucleic acid fragments encoding homologous genes from DNA or RNA.
- the polymerase chain reaction may be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the nucleic acids or nucleic acid fragments of the present invention, and the sequence of the other primer takes advantage of the presence of the poiyadenylic acid tracts to the 3' end of the mRNA precursor encoding plant genes.
- the second primer sequence may be based upon sequences derived from the cloning vector.
- a substantially purified or isolated polypeptide from a ryegrass (Lolium) or fescue (Festuca) species selected from the group consisting of SPS and SPS-like, INV and INV- like, SS and SS-like, ST and ST-like, SST and SST-like, FFT and FFT-like, SFT and SFT-like, enzymes and proteins; and functionally active fragments and variants thereof.
- the ryegrass (Lolium) or fescue (Festuca) species may be of any suitable type, including Italian or annual ryegrass, perennial ryegrass, tall fescue, meadow fescue and red fescue.
- the species is a ryegrass, more preferably perennial ryegrass (L. perenne).
- the substantially purified or isolated SPS or SPS-like polypeptide includes an amino acid sequence selected from the group consisting of sequences shown in Figures 2, 4, 7, 10, 13 and 16 hereto (Sequence ID Nos: 2, 4, 8, 12, 16 and 20, respectively); and functionally active fragments and variants thereof.
- the substantially purified or isolated INV or INV-like polypeptide includes an amino acid sequence selected from the group consisting of sequences shown in Figures 19, 22, 25, 28, 31 , 34, 37, 65 and 70 hereto (Sequence ID Nos: 25, 32, 38, 42, 60, 64, 72, 113 and 115, respectively); and functionally active fragments and variants thereof.
- the substantially purified or isolated SS or SS-like polypeptide includes an amino acid sequence selected from the group consisting of sequences shown in Figures 40, 42, 45 and 75 hereto (Sequence ID Nos: 77, 79, 84 and 117, respectively); and functionally active fragments and variants thereof.
- the substantially purified or isolated ST or ST-like polypeptide includes an amino acid sequence selected from the group consisting of sequences shown in Figures 48, 51 and 54 hereto (Sequence ID Nos: 88, 92 and 98, respectively); and functionally active fragments and variants thereof.
- the substantially purified or isolated SST or SST-like polypeptide includes an amino acid sequence shown in Figure 57 hereto (Sequence ID No: 102); and functionally active fragments and variants thereof.
- the substantially purified or isolated FFT or FFT-like polypeptide includes an amino acid sequence shown in Figure 59 hereto (Sequence ID No: 104); and functionally active fragments and variants thereof.
- the substantially purified or isolated SFT or SFT-like polypeptide includes an amino acid sequence shown in Figure 62 hereto (Sequence ID No: 111); and functionally active fragments and variants thereof.
- functionally active in relation to polypeptides it is meant that the fragment or variant has one or more of the biological properties for the proteins SPS, SPS-like, INV, INV-like, SS, SS-like, ST, ST-like, SST, SST-like, FFT, FFT- like, SFT and SFT-like, respectively.
- the functionally active fragment or variant has at least approximately 60% identity to the relevant part of the above mentioned sequence, more preferably at least approximately 80% identity, most preferably at least approximately 90% identity.
- Such functionally active variants and fragments include, for example, those having conservative amino acid substitutions of one or more residues in the corresponding amino acid sequence.
- the fragment has a size of at least 10 amino acids, more preferably at least 15 amino acids, most preferably at least 20 amino acids.
- a polypeptide recombinantly produced from a nucleic acid or nucleic acid fragment according to the present invention there is provided a polypeptide recombinantly produced from a nucleic acid or nucleic acid fragment according to the present invention.
- Techniques for recombinantly producing polypeptides are well known to those skilled in the art.
- nucleotide sequences of the present invention facilitates immunological screening of cDNA expression libraries.
- Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides may be used to immunise animals to produce polyclonal or monoclonal antibodies with specificity for peptides and/or proteins including the amino acid sequences. These antibodies may be then used to screen cDNA expression libraries to isolate full-length cDNA clones of interest.
- a genotype is the genetic constitution of an individual or group. Variations in genotype are important in commercial breeding programs, in determining parentage, in diagnostics and fingerprinting, and the like. Genotypes can be readily described in terms of genetic markers.
- a genetic marker identifies a specific region or locus in the genome. The more genetic markers, the finer defined is the genotype.
- a genetic marker becomes particularly useful when it is allelic between organisms because it then may serve to unambiguously identify an individual.
- a genetic marker becomes particularly useful when it is based on nucleic acid sequence information that can unambiguously establish a genotype of an individual and when the function encoded by such nucleic acid is known and is associated with a specific trait.
- nucleic acids and/or nucleotide sequence information including single nucleotide polymorphisms (SNP's), variations in single nucleotides between allelic forms of such nucleotide sequence, can be used as perfect markers or candidate genes for the given trait.
- SNP's single nucleotide polymorphisms
- Applicants have identified a number of SNP's of the nucleic acids and nucleic acid fragments of the present invention. These are indicated (marked with grey on the black background) in the figures that show multiple alignments of nucleotide sequences of nucleic acid fragments contributing to consensus contig sequences. See for example, Figures 5, 8, 14, 17, 20, 23, 29, 32, 35, 38, 43 and 60 (Sequence ID Nos: 5 and 6, 9 and 10, 17 and 18, 21 to 23, 26 to 30, 33 to 36, 43 to 58, 61 and 62, 65 to 70, 73 to 75, 80 to 82, and 105 to 109, respectively).
- SNP single nucleotide polymorphism
- SNP single nucleotide polymorphism
- the nucleic acid library may be of any suitable type and is preferably a cDNA library.
- the nucleic acid or nucleic acid fragment may be isolated from a recombinant plasmid or may be amplified, for example using polymerase chain reaction.
- the sequencing may be performed by techniques known to those skilled in the art.
- nucleic acids or nucleic acid fragments of the present invention including SNPs, and/or nucleotide sequence information thereof, as molecular genetic markers.
- nucleic acid or nucleic acid fragment according to the present invention and/or nucleotide sequence information thereof, as a molecular genetic marker.
- nucleic acids or nucleic acid fragments according to the present invention and/or nucleotide sequence information thereof may be used as a molecular genetic marker for quantitative trait loci (QTL) tagging, QTL mapping, DNA fingerprinting and in marker assisted selection, particularly in ryegrasses and fescues.
- QTL quantitative trait loci
- nucleic acids or nucleic acid fragments according to the present invention and/or nucleotide sequence information thereof may be used as molecular genetic markers in forage and turf grass improvement, e.g. tagging QTLs for herbage quality traits, dry matter digestibility, biotic stress tolerance, abiotic stress tolerance, plant stature, leaf and stem colour, carbohydrate content, carbohydrate storage.
- sequence information revealing SNPs in allelic variants of the nucleic acids or nucleic acid fragments of the present invention and/or nucleotide sequence information thereof may be used as molecular genetic markers for QTL tagging and mapping and in marker assisted selection, particularly in ryegrasses and fescues.
- construct including a nucleic acid or nucleic acid fragment according to the present invention.
- construct refers to an artificially assembled or isolated nucleic acid molecule which includes the gene of interest.
- a construct may include the gene or genes of interest, a marker gene which in some cases can also be the gene of interest and appropriate regulatory sequences. It should be appreciated that the inclusion of regulatory sequences in a construct is optional, for example, such sequences may not be required in situations where the regulatory sequences of a host cell are to be used.
- construct includes vectors but should not be seen as being limited thereto.
- a vector including a nucleic acid or nucleic acid fragment according to the present invention.
- vector as used herein includes both cloning and expression vectors. Vectors are often recombinant molecules including nucleic acid molecules from several sources.
- the vector may include a regulatory element such as a promoter, a nucleic acid or nucleic acid fragment according to the present invention and a terminator; said regulatory element, nucleic acid or nucleic acid fragment and terminator being operatively linked.
- a regulatory element such as a promoter, a nucleic acid or nucleic acid fragment according to the present invention and a terminator; said regulatory element, nucleic acid or nucleic acid fragment and terminator being operatively linked.
- operatively linked is meant that said regulatory element is capable of causing expression of said nucleic acid or nucleic acid fragment in a plant cell and said terminator is capable of terminating expression of said nucleic acid or nucleic acid fragment in a plant cell.
- said regulatory element is upstream of said nucleic acid or nucleic acid fragment and said terminator is downstream of said nucleic acid or nucleic acid fragment.
- the vector may be of any suitable type and may be viral or non-viral.
- the vector may be an expression vector.
- Such vectors include chromosomal, non- chromosomal and synthetic nucleic acid sequences, eg. derivatives of plant viruses; bacterial plasmids; derivatives of the Ti plasmid from Agrobacterium tumefaciens, derivatives of the Ri plasmid from Agrobacterium rhizogenes; phage DNA; yeast artificial chromosomes; bacterial artificial chromosomes; binary bacterial artificial chromosomes; vectors derived from combinations of plasmids and phage DNA.
- any other vector may be used as long as it is replicable, integrative or viable in the plant cell.
- the regulatory element and terminator may be of any suitable type and may be endogenous to the target plant cell or may be exogenous, provided that they are functional in the target plant cell.
- the regulatory element is a promoter.
- promoters which may be employed in the vectors of the present invention are well known to those skilled in the art. Factors influencing the choice of promoter include the desired tissue specificity of the vector, and whether constitutive or inducible expression is desired and the nature of the plant cell to be transformed (eg. monocotyledon or dicotyledon).
- Particularly suitable constitutive promoters include the Cauliflower Mosaic Virus 35S (CaMV 35S) promoter, the maize Ubiquitin promoter, and the rice Actin promoter.
- terminators which may be employed in the vectors of the present invention are also well known to those skilled in the art.
- the terminator may be from the same gene as the promoter sequence or a different gene.
- Particularly suitable terminators are polyadenylation signals, such as the CaMV 35S polyA and other terminators from the nopaline synthase (nos), the octopine synthase (ocs) and the rbcS genes.
- the vector in addition to the regulatory element, the nucleic acid or nucleic acid fragment of the present invention and the terminator, may include further elements necessary for expression of the nucleic acid or nucleic acid fragment, in different combinations, for example vector backbone, origin of replication (ori), multiple cloning sites, spacer sequences, enhancers, introns (such as the maize Ubiquitin Ubi intron), antibiotic resistance genes and other selectable marker genes [such as the neomycin phosphotransferase (npt2) gene, the hygromycin phosphotransferase (hph) gene, the phosphinothricin acetyltransferase (bar or pat) gene], and reporter genes (such as beta-glucuronidase (GUS) gene (gusA)].
- the vector may also contain a ribosome-binding site for translation initiation.
- the vector may also include appropriate sequences for amplifying expression.
- the presence of the vector in transformed cells may be determined by other techniques well known in the art, such as PCR (polymerase chain reaction), Southern blot hybridisation analysis, histochemical GUS assays, northern and Western blot hybridisation analyses.
- the vectors of the present invention may be incorporated into a variety of plants, including monocotyledons (such as grasses from the genera Lolium, Festuca, Paspalum, Pennisetum, Panicum and other forage and turfgrasses, corn, oat, sugarcane, wheat and barley), dicotyledons (such as arabidopsis, tobacco, white clover, red clover, subterranean clover, alfalfa, eucalyptus, potato, sugarbeet) and gymnosperms.
- monocotyledons such as grasses from the genera Lolium, Festuca, Paspalum, Pennisetum, Panicum and other forage and turfgrasses
- corn oat, sugarcane, wheat and barley
- dicotyledons such as arabidopsis, tobacco, white clover, red clover, subterranean clover, alfalfa, eucalyptus, potato, sugarbeet
- the vectors may be used to transform monocotyledons, preferably grass species such as ryegrasses (Lolium species) and fescues (Festuca species), even more preferably perennial ryegrass, including forage- and turf-type cultivars.
- the vectors are used to transform dicotyledons, preferably forage legume species such as clovers (Trifolium species) and medics (Medicago species), more preferably white clover (Trifolium repens), red clover (Trifolium pratense), subterranean clover (Trifolium subterraneum) and lucerne (Medicago sativa).
- Techniques for incorporating the vectors of the present invention into plant cells are well known to those skilled in the art. Such techniques include Agrobacterium mediated introduction, electroporation to tissues, cells and protoplasts, protoplast fusion, injection into reproductive organs, injection into immature embryos and high velocity projectile introduction to cells, tissues, calli, immature and mature embryos. The choice of technique will depend largely on the type of plant to be transformed.
- Cells incorporating the vectors of the present invention may be selected, as described above, and then cultured in an appropriate medium to regenerate transformed plants, using techniques well known in the art.
- the culture conditions such as temperature, pH and the like, will be apparent to the person skilled in the art.
- the resulting plants may be reproduced, either sexually or asexually, using methods well known in the art, to produce successive generations of transformed plants.
- a plant cell, plant, plant seed or other plant part including, e.g. transformed with, a construct or vector of the present invention.
- the plant cell, plant, plant seed or other plant part may be from any suitable species, including monocotyledons, dicotyledons and gymnosperms.
- the plant cell, plant, plant seed or other plant part is from a monocotyledon, preferably a grass species, more preferably a ryegrass (Lolium species) or fescue (Festuca species), even more preferably perennial ryegrass, including both forage- and turf-type cultivars.
- the plant cell, plant, plant seed or other plant part is from a dicotyledon, preferably forage legume species such as clovers (Trifolium species) and medics (Medicago species), more preferably white clover (Trifolium repens), red clover (Trifolium pratense), subterranean clover (Trifolium subterraneum) and lucerne (Medicago sativa).
- the present invention also provides a plant, plant seed or other plant part derived from a plant cell of the present invention.
- the present invention also provides a plant, plant seed or other plant part derived from a plant of the present invention.
- a method of modifying soluble carbohydrate metabolism and/or transport in a plant including introducing into said plant an effective amount of a nucleic acid or nucleic acid fragment, construct and/or vector according to the present invention.
- the soluble carbohydrate metabolism and/or transport may be, for example, sucrose biosynthesis and/or sucrose degradation and/or sucrose transport and/or fructan biosynthesis and/or fructan degradation.
- an effective amount is meant an amount sufficient to result in an identifiable phenotypic trait in said plant, or a plant, plant seed or other plant part derived therefrom. Such amounts can be readily determined by an appropriately skilled person, taking into account the type of plant, the route of administration and other relevant factors. Such a person will readily be able to determine a suitable amount and method of administration. See, for example, Maniatis et al, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, the entire disclosure of which is incorporated herein by reference.
- plant soluble carbohydrate metabolism and/or transport may be increased or decreased.
- sucrose biosynthesis, sucrose degradation, sucrose transport, fructan biosynthesis and/or fructan degradation may be increased, decreased or otherwise modified relative to an untransformed control plant. They may be increased or otherwise modified, for example, by incorporating additional copies of a sense nucleic acid or nucleic acid fragment of the present invention. They may be decreased or otherwise modified, for example, by incorporating an antisense nucleic acid or nucleic acid fragment of the present invention.
- the number of copies of genes encoding different enzymes in the fructan biosynthetic pathway may be manipulated to modify the degree of polymerization of the molecule synthesized, and/or the linkages between different fructose subunits in the molecule, thereby altering the composition of fructans produced.
- a fructan or modified fructan or a sucrose or modified sucrose substantially or partially purified or isolated from a plant, plant seed or other plant part of the present invention.
- Such fructan or sucrose may be modified from naturally occurring fructan or sucrose in terms of their monomeric sugar composition, the degree of linkage and/or nature of linkages between the monomers, the degree of polymerization (number of units) of the molecule.
- Figure 1 shows the nucleotide sequence of LpSPSa (Sequence ID No: 1).
- Figure 2 shows the deduced amino acid sequence of LpSPSa (Sequence ID No: 2).
- Figure 3 shows the consensus contig nucleotide sequence of LpSPSb (Sequence ID No: 3).
- Figure 4 shows the deduced amino acid sequence of LpSPSb Sequence ID No: 4).
- Figure 5 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSPSb (Sequence ID Nos: 5 and 6).
- Figure 6 shows the consensus contig nucleotide sequence of LpSPSc (Sequence ID No: 7).
- FIG. 7 shows the deduced amino acid sequence of LpSPSc (Sequence ID No: 8).
- Figure 8 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSPSc (Sequence ID Nos: 9 and 10).
- Figure 9 shows the consensus contig nucleotide sequence of LpSPSd (Sequence ID No: 11).
- FIG 10 shows the deduced amino acid sequence of LpSPSd (Sequence
- Figure 11 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSPSd (Sequence ID Nos: 13 and 14).
- Figure 12 shows the consensus contig nucleotide sequence of LpSPSe
- Figure 13 shows the deduced amino acid sequence of LpSPSe (Sequence ID No: 16).
- Figure 14 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSPSe (Sequence ID Nos:
- Figure 15 shows the consensus contig nucleotide sequence of LpSPSf (Sequence ID No: 19).
- Figure 16 shows the deduced amino acid sequence of LpSPSf (Sequence ID No: 20).
- Figure 17 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSPSf (Sequence ID Nos: 21 , 22 and 23).
- Figure 18 shows the consensus contig nucleotide sequence of LplNVa (Sequence ID No: 24).
- Figure 19 shows the deduced amino acid sequence of LplNVa (Sequence ID No: 25).
- Figure 20 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVa (Sequence ID Nos: 26 to 30).
- Figure 21 shows the consensus contig nucleotide sequence of LplNVb (Sequence ID No: 31).
- Figure 22 shows the deduced amino acid sequence of LplNVb (Sequence
- Figure 23 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVb (Sequence ID Nos: 33 to 36).
- Figure 24 shows the consensus contig nucleotide sequence of LplNVc
- Figure 25 shows the deduced amino acid sequence of LplNVc (Sequence ID No: 38).
- Figure 26 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVc (Sequence ID Nos: 39 and 40).
- Figure 27 shows the consensus contig nucleotide sequence of LplNVd (Sequence ID No: 41).
- Figure 28 shows the deduced amino acid sequence of LplNVd (Sequence ID No: 42).
- Figure 29 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVd (Sequence ID Nos: 43 to 58).
- Figure 30 shows the consensus contig nucleotide sequence of LplNVe (Sequence ID No: 59).
- Figure 31 shows the deduced amino acid sequence of LplNVe (Sequence ID No: 60).
- Figure 32 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVe (Sequence ID Nos: 61 and 62).
- Figure 33 shows the consensus contig nucleotide sequence of LplNVf (Sequence ID No: 63).
- Figure 34 shows the deduced amino acid sequence of LplNVf (Sequence
- Figure 35 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVf (Sequence ID Nos: 65 to 70).
- Figure 36 shows the consensus contig nucleotide sequence of LplNVg (Sequence ID No: 71).
- Figure 37 shows the deduced amino acid sequence of LplNVg (Sequence ID No: 72).
- Figure 38 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LplNVg (Sequence ID Nos: 73 to 75).
- Figure 39 shows the nucleotide sequence of LpSSa (Sequence ID No: 76).
- Figure 40 shows the deduced amino acid sequence of LpSSa (Sequence ID No: 77).
- Figure 41 shows the consensus contig nucleotide sequence of LpSSb (Sequence ID No: 78).
- Figure 42 shows the deduced amino acid sequence of LpSSb (Sequence ID No: 79).
- Figure 43 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSSb (Sequence ID Nos: 80 to 82).
- Figure 44 shows the consensus contig nucleotide sequence of LpSSc (Sequence ID No: 83).
- Figure 45 shows the deduced amino acid sequence of LpSSc (Sequence ID).
- Figure 46 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSSc (Sequence ID Nos: 85 and 86).
- Figure 47 shows the consensus contig nucleotide sequence of LpSTa (Sequence ID No: 87).
- Figure 48 shows the deduced amino acid sequence of LpSTa (Sequence ID No: 88).
- Figure 49 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSTa (Sequence ID Nos: 89 and 90).
- Figure 50 shows the consensus contig nucleotide sequence of LpSTb (Sequence ID No: 91).
- Figure 51 shows the deduced amino acid sequence of LpSTb (Sequence ID
- Figure 52 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSTb (Sequence ID Nos: 93 to 96).
- Figure 53 shows the consensus contig nucleotide sequence of LpSTc
- Figure 54 shows the deduced amino acid sequence of LpSTc (Sequence ID No: 98).
- Figure 55 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpSTc (Sequence ID No: 99 and 100).
- Figure 56 shows the nucleotide sequence of LpSSTa (Sequence ID No: 101).
- Figure 57 shows the deduced amino acid sequence of LpSSTa (Sequence ID No: 102).
- Figure 58 shows the consensus contig nucleotide sequence of LpFFTa (Sequence ID No: 103).
- Figure 59 shows the deduced amino acid sequence of LpFFTa (Sequence
- Figure 60 shows the nucleotide sequences of the nucleic acid fragments contributing to the consensus contig sequence LpFFTa (Sequence ID Nos: 105 to 109).
- Figure 61 shows the nucleotide sequence of LpSFTa (Sequence ID No:
- Figure 62 shows the deduced amino acid sequence of LpSFTa (Sequence ID No: 111).
- Figure 63 shows the plasmid map of the cDNA encoding perennial ryegrass Invertasel (LpCWInvertasel).
- Figure 64 shows the nucleotide sequence of perennial ryegrass Invertasel (Sequence ID No: 112).
- Figure 65 shows the deduced amino acid sequence of perennial ryegrass Invertasel cDNA (Sequence ID No: 113).
- Figure 66 shows plasmid maps of sense and antisense constructs of
- Figure 67 shows screening by Southern hybridisation for RFLPs using Lplnvertasel as a probe.
- Figure 68 shows the plasmid map of the cDNA encoding perennial ryegrass Invertase2 (LpCWInvertase2).
- Figure 69 shows the nucleotide sequence of perennial ryegrass Invertase2 (Sequence ID No: 114).
- Figure 70 shows the deduced amino acid sequence of perennial ryegrass
- Invertase2 cDNA (Sequence ID No: 115).
- Figure 71 shows plasmid maps of sense and antisense constructs of Lplnvertase2 in pDH51 transformation vector.
- Figure 72 shows screening by Southern hybridisation for RFLPs using Lplnvertase2 as a probe.
- Figure 73 shows the plasmid map of the cDNA encoding perennial ryegrass Sucrose Synthase (LpSucrose Synthase).
- Figure 74 shows the nucleotide sequence of perennial ryegrass Sucrose Synthase (Sequence ID No: 116).
- Figure 75 shows the deduced amino acid sequence of perennial ryegrass
- Sucrose Synthase cDNA (Sequence ID No: 117).
- Figure 76 shows plasmid maps of sense and antisense constructs of LpSucrose Synthase in pDH51 transformation vector.
- Figure 77 shows screening by Southern hybridisation for RFLPs using LpSucrose Synthase as a probe.
- Figure 78 shows the regeneration of transgenic tobacco plants from direct gene transfer to protoplasts of chimeric genes encoding perennial ryegrass enzymes involved in metabolism and transport of soluble carbohydrates.
- Figure 79 shows a subgrid of a microarray for the expression profiling of perennial ryegrass genes involved in metabolism and transport of soluble carbohydrates. Red represents up-regulated expression, green represents down-regulated expression and yellow represents no change in expression. For example, an overlay of microarray images probed with 10LS tissues (red) and 10DS tissues (green). Expression level is relatively expressed as up-regulated in 10LS (red), down-regulated in 10LS (green) and no change in expression (yellow).
- Figure 80 shows the genetic linkage map of perennial ryegrass NA6 showing map location of ryegrass genes encoding enzymes involved in metabolism and transport of soluble carbohydrates.
- cDNA libraries representing mRNAs from various organs and tissues of perennial ryegrass (Lolium perenne) were prepared. The characteristics of the libraries are described in Table 1.
- RNA libraries may be prepared by any of many methods available. For example, total RNA may be isolated using the Trizol method (Gibco-BRL, USA) or the RNeasy Plant Mini kit (Qiagen, Germany), following the manufacturers' instructions. cDNAs may be generated using the SMART PCR cDNA synthesis kit (Clontech, USA), cDNAs may be amplified by long distance polymerase chain reaction using the Advantage 2 PCR Enzyme system (Clontech, USA), cDNAs may be cleaned using the GeneClean spin column (Bio 101 , USA), tailed and size fractionated, according to the protocol provided by Clontech.
- Trizol method Gibco-BRL, USA
- RNeasy Plant Mini kit Qiagen, Germany
- the cDNAs may be introduced into the pGEM-T Easy Vector system 1 (Promega, USA) according to the protocol provided by Promega.
- the cDNAs in the pGEM-T Easy plasmid vector are transfected into Escherichia coli Epicurian coli XL10-Gold ultra competent cells (Stratagene, USA) according to the protocol provided by Stratagene.
- the cDNAs may be introduced into plasmid vectors for first preparing the cDNA libraries in Uni-ZAP XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA, USA).
- the Uni-ZAP XR libraries are converted into plasmid libraries according to the protocol provided by Stratagene.
- cDNA inserts will be contained in the plasmid vector pBluescript.
- the cDNAs may be introduced directly into precut pBluescript II SK(+) vectors (Stratagene) using T4 DNA ligase (New England Biolabs), followed by transfection into E. coli DH10B cells according to the manufacturer's protocol (GIBCO BRL Products).
- plasmid DNAs are prepared from randomly picked bacterial colonies containing recombinant plasmids, or the insert cDNA sequences are amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences. Plasmid DNA preparation may be performed robotically using the Qiagen QiaPrep Turbo kit (Qiagen, Germany) according to the protocol provided by Qiagen. Amplified insert DNAs are sequenced in dye-terminator sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "ESTs"). The resulting ESTs are analyzed using an Applied Biosystems ABI 3700 sequence analyser.
- the cDNA clones encoding SPS, INV, SS, ST, SST, FFT, and SFT were identified by conducting BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410) searches.
- the cDNA sequences obtained were analysed for similarity to all publicly available DNA sequences contained in the eBioinformatics nucleotide database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI).
- the DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the SWISS-PROT protein sequence database using BLASTx algorithm (v 2.0.1) (Gish and States (1993) Nature Genetics 3:266- 272) provided by the NCBI.
- the cDNA sequences obtained and identified were then used to identify additional identical and/or overlapping cDNA sequences generated using the BLASTN algorithm.
- the identical and/or overlapping sequences were subjected to a multiple alignment using the CLUSTALw algorithm, and to generate a consensus contig sequence derived from this multiple sequence alignment.
- the consensus contig sequence was then used as a query for a search against the SWISS-PROT protein sequence database using the BLASTx algorithm to confirm the initial identification.
- Full-length cDNAs were identified from our EST sequence database using relevant published sequences (NCBI databank) as queries for BLAST searches. Full-length cDNAs were identified by alignment of the query and hit sequences using Sequencher (Gene Codes Corp., AnnArbor, Ml 48108, USA). The original plasmid was then used to transform chemically competent XL-1 cells (prepared in- house, CaCl 2 protocol). After colony PCR (using HotStarTaq, Qiagen) a minimum of three PCR-positive colonies per transformation were picked for initial sequencing with M13F and M13R primers. The resulting sequences were aligned with the original EST sequence using Sequencher to confirm identity and one of the three clones was picked for full-length sequencing, usually the one with the best initial sequencing result.
- oligonucleotide primers were designed to the initial sequence and used for further sequencing. In most cases the sequencing could be done from both 5' and 3' end.
- the sequences of the oligonucleotide primers are shown in Table 2. In some instances, however, an extended poly-A tail necessitated the sequencing of the cDNA to be completed from the 5' end.
- Contigs were then assembled in Sequencher.
- the contigs include the sequences of the SMART primers used to generate the initial cDNA library as well as pGEM-T Easy vector sequence up to the EcoRI cut site both at the 5' and 3' end.
- cDNA fragments were generated by high fidelity PCR using the original pGEM-T Easy plasmid cDNA as a template.
- the primers used contained restriction sites for EcoRI and Xbal for directional and non-directional cloning into the target vector.
- a set of transgenic tobacco plants carrying chimeric Invertasel , Invertase2 and Sucrose Synthase cDNA genes from perennial ryegrass were produced.
- pDH51-based transformation vectors with Lplnvertasel , Z.plnvertase2 and LpSucrose Synthase cDNAs comprising the full open reading frame sequences in sense and antisense orientations under the control of the CaMV 35S promoter were generated.
- transgenic tobacco plants carrying the perennial ryegrass Invertasel , Invertase2 and Sucrose Synthase cDNAs under the control of the constitutive CaMV 35S promoter is described here in detail.
- the protoplast suspension was mixed gently, distributed into two 14 ml sterile plastic centrifuge tubes and carefully overlayed with 1 ml W5 solution. After centrifugation for 5 min. at 70g (Clements Orbital 500 bench centrifuge, swing-out rotor, 400 rpm), the protoplasts were collected from the interphase and transferred to one new 14 ml centrifuge tube. 10 ml W5 solution were added, the protoplasts resuspended by gentle tilting the capped tube and pelleted as before. The protoplasts were resuspended in 5-10 ml W5 solution and the yield determined by counting a 1 :10 dilution in a haemocytometer.
- the protoplasts were pelleted [70g (Clements Orbital 500 bench centrifuge, 400 rpm) for 5 min.] and resuspended in transformation buffer to a density of 1.6 x 10 6 protoplasts/ml. Care should be taken to carry over as little as possible W5 solution into the transformation mix. 300 ⁇ samples of the protoplast suspension (ca. 5 x 10 5 protoplasts) were aliquotted in 14 ml sterile plastic centrifuge tubes, 30 ⁇ l of transforming DNA were added. After carefully mixing, 300 ⁇ of PEG solution were added and mixed again by careful shaking. The transformation mix was incubated for 15 min. at room temperature with occasional shaking.
- the agarose containing the dividing protoplasts was cut into quadrants and placed in 20 ml of A medium in a 250 ml plastic culture vessel.
- the corresponding selection agent was added to the final concentration of 50 mg/l kanamycin sulphate (for npt2 expression) or 25 mg/l hygromycin B (for hph expression) or 20 mg/l phosphinotricin (for bar expression).
- Samples were incubated on a rotary shaker with 80 rpm and 1.25 cm throw at 24°C in continuous dim light.
- Resistant colonies were first seen 3-4 weeks after protoplast plating, and after a total time of 6-8 weeks protoplast-derived resistant colonies (when 2-3 mm in diameter) were transferred onto MS morpho medium solidified with 0.6% (w/v) agarose in 12-well plates and kept for the following 1-2 weeks at 24°C in continuous dim light (5 vmol m "2 s " ⁇ Osram L36 W/21 Lumilux white tubes), where calli proliferated, reached a size of 8-10 mm, differentiated shoots that were rooted on MS hormone free medium leading to the recovery of transgenic tobacco plants (Table 4, Figure 78).
- Perennial ryegrass SPS, INV, SS, ST, SST, FFT, and SFT cDNAs were either PCR-amplified or cut from their respective plasmids, gel-purified and radio- labelled for use as probes to detect restriction fragment length polymorphisms (RFLPs).
- RFLPs were mapped in the Fi (first generation) population, NA 6 x AU 6 . This population was made by crossing an individual (NA 6 ) from a North African ecotype with an individual (AU ⁇ ) from the cultivar Aurora, which is derived from a Swiss ecotype. Genomic DNA of the 2 parents and 114 progeny was extracted using the 1 x CTAB method of Fulton et al. (1995).
- Probes were screened for their ability to detect polymorphism using the
- RFLP bands segregating within the population were scored and the data was entered into an Excel spreadsheet. Alleles showing the expected 1 :1 ratio were mapped using MAPMAKER 3.0 (Lander et al. 1987). Alleles segregating from, and unique to, each parent, were mapped separately to give two different linkage maps. Markers were grouped into linkage groups at a LOD of 5.0 and ordered within each linkage group using a LOD threshold of 2.0.
- LpSPS, LplNV, LpSS, LpST, LpSST, LpFFT, and LpSFT loci mapped to the linkage groups as indicated in Table 5 and in Figure 80. These gene locations can now be used as candidate genes for quantitative trait loci for traits associated with metabolism and transport of soluble carbohydrates, such as carbohydrate content, herbage quality, dry matter digestibility, plant organ size, plant height, plant yield, carbohydrate storage, tolerance to abiotic stresses such as drought and cold.
- LpSSa (LpSucroseSynthase) Y EcoR I LpSSa.1 3 LpSSa.2 1
- RNA samples were used to extract total RNA. Fluorescence labelled probes were synthesis by reversed transcribing RNA and incorporating Cyanine 3 or 5 labelled dCTP. The probes were hybridised onto microarrays. In each case the experiment was repeated on two microarrays. After overnight (16 hours) hybridisation, the microarrays were washed and scanned using confocal laser scanner (ScanArray 3000, Packard, USA). The images obtained were quantified and analysed using lmagene 4.1 and GeneSight 2.1 (BioDiscovery, USA). Data were judged as not present (-), low expression (+), medium expression (++), high expression (+++) and highly expression (++++) (Table 7). TABLE 7 Results of expression profiling of ryegrass genes encoding enzymes involved in metabolism and transport of soluble carbohydrates
- MAPMAKER an interactive computer package for constructing primary linkage maps of experimental and natural populations. Genomics 1 : 174-181.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001295256A AU2001295256B2 (en) | 2000-10-10 | 2001-10-10 | Manipulation of soluble carbohydrates |
AU9525601A AU9525601A (en) | 2000-10-10 | 2001-10-10 | Manipulation of soluble carbohydrates |
NZ524587A NZ524587A (en) | 2000-10-10 | 2001-10-10 | Enzymes from ryegrass (Lolium) and fescue (Festuca) species |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR0673A AUPR067300A0 (en) | 2000-10-10 | 2000-10-10 | Manipulation of soluble carbohydrates |
AUPR0673 | 2000-10-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002031130A1 true WO2002031130A1 (en) | 2002-04-18 |
WO2002031130A9 WO2002031130A9 (en) | 2003-08-14 |
Family
ID=3824731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU2001/001275 WO2002031130A1 (en) | 2000-10-10 | 2001-10-10 | Manipulation of soluble carbohydrates |
Country Status (3)
Country | Link |
---|---|
AU (3) | AUPR067300A0 (en) |
NZ (5) | NZ575554A (en) |
WO (1) | WO2002031130A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003040306A2 (en) * | 2001-11-07 | 2003-05-15 | Genesis Research And Development Corporation Limited | Compositions from the grasses lolium perenne and festuca arundinacea |
WO2003093464A1 (en) * | 2002-05-06 | 2003-11-13 | Genesis Research And Development Corporation Limited | Compositions isolated from forage grasses and methods for their use |
WO2023001294A1 (en) * | 2021-07-22 | 2023-01-26 | 深圳先进技术研究院 | Method for producing glucose and derivatives thereof by means of biotransformation with recombinant yeast |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000563A1 (en) * | 1992-06-24 | 1994-01-06 | Institut Für Genbiologische Forschung Berlin Gmbh | Dna sequences and plasmids for the preparation of plants with changed sucrose concentration |
US5981852A (en) * | 1990-07-20 | 1999-11-09 | Calgene Llc | Modification of sucrose phosphate synthase in plants |
-
2000
- 2000-10-10 AU AUPR0673A patent/AUPR067300A0/en not_active Abandoned
-
2001
- 2001-10-10 AU AU2001295256A patent/AU2001295256B2/en not_active Ceased
- 2001-10-10 NZ NZ575554A patent/NZ575554A/en not_active IP Right Cessation
- 2001-10-10 NZ NZ524587A patent/NZ524587A/en not_active IP Right Cessation
- 2001-10-10 NZ NZ536967A patent/NZ536967A/en not_active IP Right Cessation
- 2001-10-10 NZ NZ547618A patent/NZ547618A/en not_active IP Right Cessation
- 2001-10-10 NZ NZ561249A patent/NZ561249A/en not_active IP Right Cessation
- 2001-10-10 WO PCT/AU2001/001275 patent/WO2002031130A1/en active IP Right Grant
- 2001-10-10 AU AU9525601A patent/AU9525601A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981852A (en) * | 1990-07-20 | 1999-11-09 | Calgene Llc | Modification of sucrose phosphate synthase in plants |
WO1994000563A1 (en) * | 1992-06-24 | 1994-01-06 | Institut Für Genbiologische Forschung Berlin Gmbh | Dna sequences and plasmids for the preparation of plants with changed sucrose concentration |
Non-Patent Citations (44)
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003040306A2 (en) * | 2001-11-07 | 2003-05-15 | Genesis Research And Development Corporation Limited | Compositions from the grasses lolium perenne and festuca arundinacea |
WO2003040306A3 (en) * | 2001-11-07 | 2004-02-19 | Genesis Res & Dev Corp Ltd | Compositions from the grasses lolium perenne and festuca arundinacea |
US7154027B2 (en) | 2001-11-07 | 2006-12-26 | Jeroen Demmer | Compositions isolated from forage grasses and methods for their use |
AU2002360228B2 (en) * | 2001-11-07 | 2008-04-10 | Genesis Research And Development Corporation Limited | Compositions from the grasses lolium perenne and festuca arundinacea |
AU2002360228B8 (en) * | 2001-11-07 | 2008-12-04 | Genesis Research And Development Corporation Limited | Compositions from the grasses lolium perenne and festuca arundinacea |
US7732661B2 (en) | 2001-11-07 | 2010-06-08 | Jeroen Demmer | Compositions isolated from forage grasses and methods for their use |
US8003849B2 (en) | 2001-11-07 | 2011-08-23 | Jeroen Demmer | Compositions isolated from forage grasses and methods for their use |
WO2003093464A1 (en) * | 2002-05-06 | 2003-11-13 | Genesis Research And Development Corporation Limited | Compositions isolated from forage grasses and methods for their use |
AU2003228165B2 (en) * | 2002-05-06 | 2008-05-08 | Genesis Research And Development Corporation Limited | Compositions isolated from forage grasses and methods for their use |
AU2008255238B2 (en) * | 2002-05-06 | 2012-06-28 | Genesis Research And Development Corporation Limited | Compositions isolated from forage grasses and methods for their use |
WO2023001294A1 (en) * | 2021-07-22 | 2023-01-26 | 深圳先进技术研究院 | Method for producing glucose and derivatives thereof by means of biotransformation with recombinant yeast |
Also Published As
Publication number | Publication date |
---|---|
AUPR067300A0 (en) | 2000-11-02 |
NZ547618A (en) | 2007-10-26 |
NZ575554A (en) | 2010-12-24 |
NZ536967A (en) | 2007-05-31 |
AU2001295256B2 (en) | 2007-10-25 |
AU9525601A (en) | 2002-04-22 |
WO2002031130A9 (en) | 2003-08-14 |
NZ524587A (en) | 2005-01-28 |
NZ561249A (en) | 2009-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011202252B2 (en) | Manipulation of plant cell walls (3) | |
AU2002210243B2 (en) | Manipulation of flowering and plant architecture | |
AU2002210243A1 (en) | Manipulation of flowering and plant architecture | |
AU2001293497A1 (en) | Manipulation of plant cell walls | |
AU2001295256B2 (en) | Manipulation of soluble carbohydrates | |
AU2013202733B2 (en) | Manipulation of soluble carbohydrates (5) | |
AU2001295256A1 (en) | Manipulation of soluble carbohydrates | |
AU2012202979B2 (en) | Manipulation of soluble carbohydrates (3) | |
AU2007237376B2 (en) | Manipulation of soluble carbohydrates (2) | |
AU2013202704B2 (en) | Manipulation of plant cell walls (4) | |
AU2013202724B2 (en) | Modification of plant and seed development and plant responses to stresses and stimuli (6) | |
WO2002090547A1 (en) | Modification of plant and seed development and plant responses to stresses and stimuli | |
AU2002252825A1 (en) | Modification of plant and seed development and plant responses to stresses and stimuli | |
AU2012200604B2 (en) | Manipulation of flowering and plant architecture (3) | |
AU2007231631A1 (en) | Manipulation of flowering and plant architecture (2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001295256 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 524587 Country of ref document: NZ |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-161, SEQUENCE LISTING, ADDED |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 524587 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 524587 Country of ref document: NZ |
|
NENP | Non-entry into the national phase |
Ref country code: JP |